The Chen Student Map

Chapter 245: The Chen Student Map The FDA names arrived while Leah was still carrying Diana's hospital screenshots through Margaret's security vestibule, and the guard would not unlock the inner door until Leah put her phone faceup in the evidence tray. "It came through Okafor's channel," Leah said. "Then it can wait ten seconds," the guard said, unmoved. "Phones stay visible until counsel clears them." Leah wanted to snap at him. Instead she looked through the glass at Margaret's conference room, where Diana was already seated with the P&C folder pressed flat under both palms. They had an archive number that could prove how Martha erased Isabella Rose Voss. Ethan had sent the names of federal officials who might explain why no agency had stopped it. The two facts had arrived too close together to feel accidental. Margaret opened the inner door herself. "Bring it in." Leah set the phone on the table. Ethan's report filled the screen in clean, professional lines that made the ugliness underneath worse. Dr. Michael Torres. FDA Office of New Drugs. Director. Approved Thorne Foundation-funded clinical trial protocols with below-standard data integrity. Declined discrepancy complaints from 2019 to 2023. Hunt Capital healthcare conference speaking fee, 2021. Dr. Rachel Kim. FDA Office of Surveillance and Epidemiology. Deputy Director. Suppressed adverse event reports for NexGen Therapeutics products. Delayed safety reviews for Thorne-funded pharmaceutical acquisitions. Former colleague of Dr. Sarah Chen. Dr. David Walsh. FDA Office of Compliance. Senior Investigator. Cleared Thorne-funded trial inspections despite documented manipulation. Hunt Capital fellowship funding, 2008 to 2010. Diana read the names once and sat back. "These are not clerks." "No," Margaret said. "These are choke points." Leah heard the word land in the room. Choke points. Not vague influence, not social acquaintance, not corruption hidden in a donor dinner. Torres could approve the trial design. Kim could bury the harm after the drug touched patients. Walsh could walk into a lab, see the false data, and write that nothing was wrong. Margaret took a marker and drew three red dots on the whiteboard under FDA. "Tell me what Ethan says about total placement." Leah scrolled. "Estimate twenty to twenty-five Chen students across FDA, SEC, DOJ, and possibly other agencies. Acceleration from 2012 to 2019 aligns with Hunt patriarch expansion." Richard, joining by video from Thorne Group's counsel room, closed his eyes for one second. "That is when Hunt pushed the healthcare acquisitions." "And when Martha stopped fearing audits," Leah said. Margaret pointed the marker at her. "Say that again." Leah stood. Her legs still felt weak from the P&C number, but anger steadied her better than any chair could. "Martha did not avoid exposure because everyone was stupid. She avoided exposure because the reports went to people Chen had already placed. Clinical-trial complaints, Foundation filings, NexGen safety warnings, Veritas inspections. Every alarm entered an office where someone had been trained to smother it." Diana's face had gone pale. "So when James found the clinical-trial fraud..." "The agency would not have saved him," Leah said. "Not if Chen's students were already inside." The sentence hurt the room. It made the Voss murders feel less like an old crime and more like a mechanism still running. Margaret capped the marker. "This is our second track. Martha's trial proves the murder, theft, and identity construction. Chen's student map proves system protection. We do not blend them in court unless Okafor decides it serves the indictment. But we preserve every thread." Leah looked down at the names. "Ethan says SEC next." "Good. Have him send it only through Okafor. No direct messages." "He did." Margaret glanced at Leah, registering the answer and the cost behind it. "Professional only is working." "Professional only is easier when the evidence is louder than the history." No one challenged that. At 1:17, Margaret's office phone rang. She picked up, listened, and motioned everyone silent. Leah watched the shape of the answer before she heard it: Margaret's shoulders lowered half an inch. "You have the box?" Margaret asked. "No, Arthur. Do not read it to me from the lobby. Seal it. Put your initials across the flap. Ask the records clerk to sign the access log and photograph the log before you leave. If anyone asks what you pulled, you call me before you answer." Webb's voice leaked thinly through the receiver. Leah caught only pieces. Box intact. File present. Old hospital correspondence. Margaret's eyes lifted to Leah. "Courier. Not firm messenger. Mine." Another pause. "Then wait in the records room until the courier arrives." She hung up. For one second the room did not breathe. "The file is there," Margaret said. Diana covered her mouth. Richard's video feed went still. Leah looked at the whiteboard, at the FDA dots, because if she looked at Diana's folder she might break before the memo arrived. "When?" Leah asked. "Within the hour." "What exactly did Webb say?" "The hospital correspondence file exists inside the M. Alden box. He has not opened the inner document stack. He saw the cover sheet and the archive number." Leah nodded. It was not the memo yet. It was not proof until Margaret logged it, read it, and tied it to the payment, custody order, and Pemberton's chain. Still, a sealed file was more than a ghost in an index. Diana reached across the table and touched Leah's wrist. "Your parents' names may be in there." Leah almost pulled away. Then she let Diana's hand stay. "Or Reinhardt's." Margaret's expression hardened. "If Reinhardt signed a confirmation, Okafor confronts him before the defense hears a whisper. His prior testimony becomes incomplete at best, obstructive at worst." Leah remembered Reinhardt on the stand, dignified, useful, careful. He had named clinical fraud. He had authenticated documents. He had looked like a man making amends. If his signature sat on the hospital alteration, he had also chosen which truth to keep back. Ethan's second message came at 2:04. SEC names confirmed. Sarah Jenkins, Division of Corporation Finance. Robert Chen, Division of Enforcement. Foundation filings cleared. NexGen complaints declined. Hunt fellowship trail. Margaret read the message and added two more red dots under SEC. "Five confirmed." "And DOJ within forty-eight hours," Leah said. "Then Chen is no longer a retired academic in Martha's shadow. She is an active architect of obstruction." Richard spoke from the screen. "Thorne Group can preserve every filing Jenkins reviewed, every complaint Chen declined, every outside counsel note connected to the Foundation. Counsel will hate the scope." "Counsel can be unhappy in writing," Margaret said. That earned a small, exhausted smile from Diana. It vanished when the outer office intercom buzzed. Margaret pressed the speaker. "Yes?" "Courier for you. Sealed legal envelope from Arthur Webb." Leah stood before anyone told her to. The folder, the FDA names, the SEC dots, the whole map of buried alarms faded behind the sound of one envelope arriving at a door. Margaret looked at her. "No touching until it is logged." "I know." "Leah." She forced her hands open at her sides. The courier entered with a brown envelope held in both hands. Webb's initials crossed the flap in blue ink. Beneath them, in a records clerk's cramped handwriting, was the number Leah had memorized on the side of the expressway. P&C-2002-0929-047. Margaret signed the receipt, opened a new evidence bag, and slid the envelope inside without breaking the seal. "We read it together," she said. Leah could hear her own heartbeat. "And if Reinhardt signed it?" Margaret picked up a letter opener. "Then tomorrow morning," she said, "Okafor takes this document to his front door."